# Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

> **NCT05858710** · PHASE1 · COMPLETED · sponsor: **Thermosome GmbH** · enrollment: 8 (actual)

## Conditions studied

- Sarcoma, Soft Tissue

## Interventions

- **DRUG:** DPPG2-TSL-DOX
- **DRUG:** Dexrazoxane

## Key facts

- **NCT ID:** NCT05858710
- **Lead sponsor:** Thermosome GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-19
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-05-28
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05858710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05858710, "Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05858710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*